Testing a clot-stopping product in open abdominal aorta surgery
Part of Heart & circulation clinical trials.
This study looks at how well a hemostatic (bleeding-stopping) product called PuraBond works during open surgery for an abdominal aortic aneurysm or severe narrowing/blockage of the aorta/iliac arteries. It’s intended for people whose surgeon thinks standard methods may not fully stop bleeding.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 years or older, and you have an abdominal aortic aneurysm or severe narrowing/blockage of the abdominal aorta or iliac arteries
- You will have open surgery on the abdominal aorta (planned, urgent, or emergency) at San Raffaele Hospital
- The surgeon plans to use PuraBond because standard bleeding control may not be enough
- Your blood and clotting tests, and your liver tests, are not abnormal before surgery
- You can sign the study consent form
- You are not pregnant or breastfeeding, and you won’t plan pregnancy for the next 24 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial surveys surgeons about how they use hemostatic agents (medications that stop bleeding during surgery). It aims to understand current practices and improve patient safety.
This study tests a special patch called TachoSil against a standard surgical pad (Surgicel) to see which works better for controlling minor oozing during open abdominal, chest, or pelvic surgeries. It may be an option if you are having certain types of surgery and have a small area of mild bleeding that needs help to stop.
This trial tests a device that seals the puncture site in the femoral artery after a catheter procedure. It may help stop bleeding faster and get you walking sooner.
This trial studies which blood-thinning medicine combination is safest and most helpful after coronary bypass surgery combined with a procedure to unblock the artery (endarterectomy). It focuses on preventing dangerous blood clots while also avoiding excess bleeding.
This trial tests if a drug called a PCSK9 inhibitor can help people undergoing open surgery for an abdominal aortic aneurysm. It aims to see if the drug affects the aneurysm in a way that might improve outcomes.
This trial looks at whether a “drug-coated balloon” used during a heart procedure (PCI) is safer or better for people who are at higher risk of bleeding while on blood thinners. It may help reduce complications around the time of the procedure in people like you.
Hear when a new Hemostatic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.